Viewing Study NCT05411757


Ignite Creation Date: 2025-12-24 @ 6:42 PM
Ignite Modification Date: 2026-05-10 @ 8:44 PM
Study NCT ID: NCT05411757
Status: UNKNOWN
Last Update Posted: 2022-06-09
First Post: 2022-06-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver Cancer
Sponsor:
Organization: